Furen Pharmaceutical Group Industry Co., Ltd. breached its 50 day moving average in a Bearish Manner : 600781-CN : September 14, 2017

*Disclaimer : This is as of previous day’s closing price.

Technical Indicators

Below is a quick look at 5 technical indicators for Furen Pharmaceutical Group Industry Co., Ltd.. More studies are available on the Technical Chart.

Indicator Signal
Closing Price above/below 50 Day Moving Average Bearish
Closing Price above/below 200 Day Moving Average Bullish
50 Day Moving Average above/below 200 Day Moving Average Bullish
RSI Reading Level (<30 or >70) Fair Value
MACD Compared to 9D EMA Signal Line Bearish

View these and more technical studies for Furen Pharmaceutical Group Industry Co., Ltd.

Share Price Performance Relative to Peers

With respect to peers, relative outperformance over the last year is in contrast to the more recent underperformance.

600781-CN‘s change in share price of 28.08% for the last 12 months is better than its peer median. However, the 30-day trend in its share price performance of -5.26% is below the peer median suggesting that the company’s recent performance has faded significantly relative to peers.

Share Price Performance

Quadrant label definitions. Hover to know more

Leading, Fading, Lagging, Rising

Screen for companies using relative share price performance

Earnings Momentum

Furen Pharmaceutical Group Industry Co., Ltd. has an earnings score of 19.85 and has a relative valuation of OVERVALUED.

Stocks with High Earnings Momentum are a preferred option for momentum plays. If they are undervalued, it can be a further advantage and may indicate sustained momentum.

Earnings Momentum Vs Relative Valuation

Quadrant label definitions. Hover to know more

Overvalued, High Earnings Momentum, Undervalued, High Earnings Momentum, UnderValued, Low Earnings Momentum, Overvalued, Low Earnings Momentum

Screen for companies using Earnings Momentum Score

Disclaimer

The information presented in this report has been obtained from sources deemed to be reliable, but AnalytixInsight does not make any representation about the accuracy, completeness, or timeliness of this information. This report was produced by AnalytixInsight for informational purposes only and nothing contained herein should be construed as an offer to buy or sell or as a solicitation of an offer to buy or sell any security or derivative instrument. This report is current only as of the date that it was published and the opinions, estimates, ratings and other information may change without notice or publication. Past performance is no guarantee of future results. Prior to making an investment or other financial decision, please consult with your financial, legal and tax advisors. AnalytixInsight shall not be liable for any party’s use of this report. AnalytixInsight is not a broker-dealer and does not buy, sell, maintain a position, or make a market in any security referred to herein. One of the principal tenets for us at AnalytixInsight is that the best person to handle your finances is you. By your use of our services or by reading any of our reports, you’re agreeing that you bear responsibility for your own investment research and investment decisions. You also agree that AnalytixInsight, its directors, its employees, and its agents will not be liable for any investment decision made or action taken by you and others based on news, information, opinion, or any other material generated by us and/or published through our services. For a complete copy of our disclaimer, please visit our website www.analytixinsight.com.